Daniel Dhumeaux spends much of his time researching Internal medicine, Gastroenterology, Steatosis, Hepatitis C virus and Pathology. Internal medicine is closely attributed to Endocrinology in his research. His Gastroenterology research is multidisciplinary, relying on both Antibiotics and Rifampicin.
His study in Steatosis is interdisciplinary in nature, drawing from both Fibrosis and Cirrhosis. His Hepatitis C virus research is multidisciplinary, incorporating elements of Liver disease and Hepatitis. His research in Pathology intersects with topics in Ultrasonography, Radiology and Focal nodular hyperplasia.
Daniel Dhumeaux mostly deals with Internal medicine, Gastroenterology, Virology, Hepatitis C virus and Endocrinology. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Chronic hepatitis. His Gastroenterology study integrates concerns from other disciplines, such as Liver biopsy and Hepatitis.
The study of Hepatitis C virus is intertwined with the study of Hepatitis C in a number of ways. His Endocrinology research focuses on Hepatic stellate cell in particular. His study brings together the fields of Pathology and Cirrhosis.
Daniel Dhumeaux mainly investigates Internal medicine, Gastroenterology, Chronic hepatitis, Steatosis and Fibrosis. Daniel Dhumeaux has researched Internal medicine in several fields, including Oncology and Hepatitis C virus. His primary area of study in Gastroenterology is in the field of Cirrhosis.
His research integrates issues of Liver disease and Intensive care medicine in his study of Chronic hepatitis. His Steatosis study combines topics in areas such as Univariate analysis and Alcoholic hepatitis. The various areas that he examines in his Fibrosis study include Scoring system, Surgery and Risk factor.
His main research concerns Internal medicine, Gastroenterology, Hepatitis C, Fibrosis and Steatosis. His work deals with themes such as Chronic hepatitis, Boceprevir, Surgery and Hepatitis C virus, which intersect with Internal medicine. Within one scientific family, he focuses on topics pertaining to Liver biopsy under Gastroenterology, and may sometimes address concerns connected to Phlebotomy and Chronic liver disease.
His Hepatitis C research includes themes of Odds ratio, Ribavirin and Randomized controlled trial. His Fibrosis study incorporates themes from Pediatrics and Risk factor. His study looks at the intersection of Steatosis and topics like Univariate analysis with Hepatic fibrosis, Biopsy and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Michael W. Fried;Mitchell L. Shiffman;K. Rajender Reddy;Coleman Smith.
The New England Journal of Medicine (2002)
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
Marianne Ziol;Adriana Handra-Luca;Adrien Kettaneh;Christos Christidis.
Hepatology (2005)
Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study
Jean-Michel Pawlotsky;Mustapha Ben Yahia;Chantal Andre;Marie-Catherine Voisin.
Hepatology (1994)
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.
Peter Ferenci;Michael W. Fried;Mitchell L. Shiffman;Coleman I. Smith.
Journal of Hepatology (2005)
Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
Nathalie Ganne-Carrié;Marianne Ziol;Victor de Ledinghen;Catherine Douvin.
Hepatology (2006)
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
Christophe Corpechot;Ahmed El Naggar;Armelle Poujol-Robert;Marianne Ziol.
Hepatology (2006)
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.
Victor de Lédinghen;Catherine Douvin;Adrien Kettaneh;Marianne Ziol.
Journal of Acquired Immune Deficiency Syndromes (2006)
Characteristics of patients with dual infection by hepatitis B and C viruses
Jean-Pierre Zarski;Benoit Bohn;Anne Bastie;Jean-Michel Pawlotsky.
Journal of Hepatology (1998)
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.
Christophe Duvoux;David Zanditenas;Christophe Hézode;Anthony Chauvat.
Hepatology (2002)
Relationship between Hepatitis C Virus Genotypes and Sources of Infection in Patients with Chronic Hepatitis C
Jean-Michel Pawlotsky;Laurent Tsakiris;Françoise Roudot-Thoraval;Claire Pellet.
The Journal of Infectious Diseases (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Université Paris Cité
Université Paris Cité
Grenoble Alpes University
University of Montpellier
Université Paris Cité
Université Paris Cité
Université Paris Cité
Grenoble Alpes University
Paris-Est Créteil University
Yeungnam University
Aston University
Sandia National Laboratories
University of Houston
China University of Geosciences
Indiana University
Centre de Coopération Internationale en Recherche Agronomique pour le Développement
Max Planck Institute for Chemistry
Max Planck Society
University of York
University of Washington
Fred Hutchinson Cancer Research Center
Mount Sinai Beth Israel
University of Eastern Finland
University of Sheffield
University of Paris-Saclay